Surya Oto Wijaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Surya Oto Wijaya has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Aninda Dinar Widiantari
Clinical Research Unit, Sulianti Saroso Infectious Disease Hospital, Jakarta, Indonesia
1 shared publication - Dian Wahyu Tanjung
Department of Clinical Pathology, Sulianti Saroso Infectious Disease Hospital, Indonesia
1 shared publication - Farida Murtiani
Doctoral Program of Epidemiology, Faculty of Public Health, Universitas Indonesia, Indonesia
1 shared publication - Maria Lawrensia Tampubolon
Department of Neurology, Sulianti Saroso Infectious Disease Hospital, Jakarta, Indonesia
1 shared publication - Nina Mariana
Affiliations Doctoral program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Directorate Of Human Resources-Education and Research, National Infectious Disease Center - Sulianti Saroso Hospital, Jakarta, Indonesia
1 shared publication - Rosamarlina Rosamarlina
Sulianti Saroso Infectious Diseases Hospital, Jakarta, Indonesia
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2710-2716
Profile of Invasive Fungal Diseases (IFD) among Severely Critically Ill non-neutropenic patients in the HCU or ICU at a Single Referral Hospital in Indonesia
Invasive fungal diseases (IFD) are responsible for more than 1.5 million deaths globally annually. Candida spp. and Aspergillus spp. are the most frequent causes of healthcare-associated fungal infections, particularly in critically ill patients. This study aimed to describe severely critically ill patients with IFD caused by Candida spp. and Aspergillus spp. A cross-sectional study was conducted from July to December 2021 in the High Care Unit (HCU) and Intensive Care Unit (ICU) of Sulianti Saroso Hospital. We enrolled non-neutropenic patients with pneumonia or sepsis. Blood, lung exudate, and urine samples were collected from each patient for fungal testing. We performed mycological examination by culture and serology (galactomannan test used to detect Aspergillus antigen). Proven, probable, and possible are proposed as levels of IFD probability. Descriptive statistics were used to summarize the variables. Among 67 severely crititcally ill patients in the HCU and ICU who met the criteria. Blood samples were collected from 48 males and 19 females and then investigated. Most patients experienced pneumonia (87.0%), respiratory failure (76.1%), and sepsis (56.7%). Candida albicans was most commonly found in sputum (28.4%) and urine (25.4%), while Aspergillus fumigatus was found in sputum (3.0%). Candida parapsilosis and Candida duobushaeminlonii were found in the blood (4.5% and 1.5%, respectively), which is causing probable and possible IFDs. This study showed that invasive fungal disease was identified in non-neutropenic patients with severe to critical cases at HCU/ICU. The main cause of IFD is Candida albicans, while a small number of cases are caused by Aspergillus fumigatus, Aspergillus flavus, and Aspergillus niger. The fungi are commonly found in sputum and urine, whereas Candida duobushaemulonii and Candida parapsilosis were detected in blood cultures.
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2710-2716
Open AccessProfile of Invasive Fungal Diseases (IFD) among Severely Critically Ill non-neutropenic patients in the HCU or ICU at a Single Referral Hospital in Indonesia
Invasive fungal diseases (IFD) are responsible for more than 1.5 million deaths globally annually. Candida spp. and Aspergillus spp. are the most frequent causes of healthcare-associated fungal infections, particularly in critically ill patients. This study aimed to describe severely critically ill patients with IFD caused by Candida spp. and Aspergillus spp. A cross-sectional study was conducted from July to December 2021 in the High Care Unit (HCU) and Intensive Care Unit (ICU) of Sulianti Saroso Hospital. We enrolled non-neutropenic patients with pneumonia or sepsis. Blood, lung exudate, and urine samples were collected from each patient for fungal testing. We performed mycological examination by culture and serology (galactomannan test used to detect Aspergillus antigen). Proven, probable, and possible are proposed as levels of IFD probability. Descriptive statistics were used to summarize the variables. Among 67 severely crititcally ill patients in the HCU and ICU who met the criteria. Blood samples were collected from 48 males and 19 females and then investigated. Most patients experienced pneumonia (87.0%), respiratory failure (76.1%), and sepsis (56.7%). Candida albicans was most commonly found in sputum (28.4%) and urine (25.4%), while Aspergillus fumigatus was found in sputum (3.0%). Candida parapsilosis and Candida duobushaeminlonii were found in the blood (4.5% and 1.5%, respectively), which is causing probable and possible IFDs. This study showed that invasive fungal disease was identified in non-neutropenic patients with severe to critical cases at HCU/ICU. The main cause of IFD is Candida albicans, while a small number of cases are caused by Aspergillus fumigatus, Aspergillus flavus, and Aspergillus niger. The fungi are commonly found in sputum and urine, whereas Candida duobushaemulonii and Candida parapsilosis were detected in blood cultures.